Synonym: (T-4)-[(1E,6E)-1,7-bis[4-(Dimethylamino)phenyl]-1,6-heptadiene-3,5-dionato-?O3,?O5]difluoroboron
CAS Number: 1193447-34-5
Empirical Formula (Hill Notation): C23H25BF2N2O2
Molecular Weight: 410.26
Linear Formula: C23H25BF2N2O2
Product Type: Chemical
This image is provided for informative purposes only and does not represent an actual product label. It should not be used as a substitute for official product labeling.
| assay |
≥98% (HPLC) |
| color |
, dark blue to black |
| form |
powder |
| InChI |
1S/C23H25BF2N2O2/c1-27(2)20-11-5-18(6-12-20)9-15-22-17-23(30-24(25,26)29-22)16-10-19-7-13-21(14-8-19)28(3)4/h5-17H,1-4H3/b15-9+,16-10+ |
| InChI key |
PVXQJYXODFZTBR-KAVGSWPWSA-N |
| Quality Level |
100  |
| SMILES string |
[B-]1([O+]=C(C=C(O1)C=Cc3ccc(cc3)N(C)C)C=Cc2ccc(cc2)N(C)C)(F)F |
| solubility |
DMSO: 0.2 mg/mL, clear (warmed) |
| storage condition |
desiccated |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
CRANAD 2 is a near-infrared (NIR) Aβ plaque-specific fluorescent probe. |
| Biochem/physiol Actions: |
CRANAD 2 is a near-infrared (NIR) Aβ plaque-specific fluorescent probe. CRANAD 2 penetrates the blood brain barrier and has a high affinity for Aβ aggregates with a Kd of 38 nM. Upon interacting with Aβ aggregates, CRANAD 2 exhibits a 70-fold increase in fluorescence intensity accompanied by a 90 nm blue shift from 805 to 715 nm and a large increase in quantum yield. CRANAD 2 has been used to detect Aβ deposits noninvasively in vivo in transgenic Tg2576 mice. |
| Packaging: |
5, 25 mg in glass bottle |
| Symbol |
GHS07 |
| Signal word |
Warning |
| Hazard statements |
H315 - H319 |
| Precautionary statements |
P305 + P351 + P338 |
| Hazard Codes |
Xi |
| Risk Statements |
36/38 |
| Safety Statements |
26 |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |